2,785
Views
1
CrossRef citations to date
0
Altmetric
Coronaviruses

CRISPR-based assay reveals SARS-CoV-2 RNA dynamic changes and redistribution patterns in non-human primate model

ORCID Icon, , , , , , , , ORCID Icon, , & show all
Pages 629-638 | Received 03 Nov 2021, Accepted 31 Jan 2022, Published online: 21 Feb 2022

References

  • Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020 May 12;323(18):1843–1844.
  • Bwire GM, Majigo MV, Njiro BJ, et al. Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis. J Med Virol. 2021 Feb;93(2):719–725.
  • Kinloch NN, Ritchie G, Brumme CJ, et al. Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results. J Infect Dis. 2020 Sep 15;222(6):899–902.
  • Kucirka LM, Lauer SA, Laeyendecker O, et al. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020 Aug 18;173(4):262–267.
  • Mallett S, Allen AJ, Graziadio S, et al. At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data. BMC Med. 2020 Nov 4;18(1):346.
  • Xiao AT, Tong YX, Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence. J Med Virol. 2020 Oct;92(10):1755–1756.
  • Wolfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020 May;581(7809):465–469.
  • Fajnzylber J, Regan J, Coxen K, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020 Oct 30;11(1):5493.
  • Veyer D, Kerneis S, Poulet G, et al. Highly sensitive quantification of plasma SARS-CoV-2 RNA shelds light on its potential clinical value. Clin Infect Dis. 2021 Nov 2;73(9):e2890–e2897.
  • Huang Z, Ning B, Yang HS, et al. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection. J Clin Invest. 2021 Apr 1;131(7):e146031.
  • Centers for Disease Control and Prevention. Symptoms of COVID-19. 2021 [updated 2021.02.22; cited 2021 2021.07.07]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
  • Deng W, Bao L, Liu J, et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020 Aug 14;369(6505):818–823.
  • Munster VJ, Feldmann F, Williamson BN, et al. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020 Sep;585(7824):268–272.
  • Johansen MD, Irving A, Montagutelli X, et al. Animal and translational models of SARS-CoV-2 infection and COVID-19. Mucosal Immunol. 2020 Nov;13(6):877–891.
  • Binnie A, Fernandes E, Almeida-Lousada H, et al. CRISPR-based strategies in infectious disease diagnosis and therapy. Infection. 2021 Jun;49(3):377–385.
  • Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 2018 Apr 27;360(6387):439–444.
  • Strohkendl I, Saifuddin FA, Rybarski JR, et al. Kinetic basis for DNA target specificity of CRISPR-Cas12a. Mol Cell. 2018 Sep 6;71(5):816–824.
  • Huang Z, Tian D, Liu Y, et al. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis. Biosens Bioelectron. 2020 Sep 15;164:112316.
  • Edwards DA, Ausiello D, Salzman J, et al. Exhaled aerosol increases with COVID-19 infection, age, and obesity. Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):e2021830118.
  • Centers for Disease Control and Prevention. Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing. 2021 [updated 2021.02.26; cited 2021.07.15 2021.07.15]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html.
  • Munoz-Fontela C, Dowling WE, Funnell SGP, et al. Animal models for COVID-19. Nature. 2020 Oct;586(7830):509–515.
  • Patel A, Jernigan DB, nCo VCDCRT. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak – United States, December 31, 2019–February 4, 2020. Am J Transplant. 2020 Mar;20(3):889–895.
  • Stadnytskyi V, Anfinrud P, Bax A. Breathing, speaking, coughing or sneezing: what drives transmission of SARS-CoV-2? J Intern Med. 2021 Nov;290(5):1010–1027.
  • Hagman K, Hedenstierna M, Gille-Johnson P, et al. SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study. Clin Infect Dis. 2021 Nov 2;73(9): e2995–e3001.
  • Prebensen C, Myhre PL, Jonassen C, et al. SARS-CoV-2 RNA in plasma is associated with ICU admission and mortality in patients hospitalized with COVID-19. Clin Infect Dis. 2021 Aug 2;73(3): e799–e802.
  • Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in zhejiang province, China, January-march 2020: retrospective cohort study. Br Med J. 2020 Apr 21;369:m1443.
  • Kim M-C, Cui C, Shin K-R, et al. Duration of culturable SARS-CoV-2 in hospitalized patients with COVID-19. N Engl J Med. 2021;384(7):671–673.
  • Andersson MI, Arancibia-Carcamo CV, Auckland K, et al. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020;5:181.